Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Letter to the Editor

Clinical Potential of Photodynamic Therapy in Skin Disorder

Author(s): Arun Kumar Singh, Rishabha Malviya* and Swati Verma

Volume 23, Issue 2, 2023

Published on: 14 September, 2022

Article ID: e070922208600 Pages: 3

DOI: 10.2174/1871526522666220907113617

[1]
Von Tappeiner H, Jodlbauer A. Die sensibilisierende Wirkung fluoreszierender Substanzen: Gesammelte Untersuchungen uber die photo-dynamische Erscheinung (The sensitizing action of fluorescent substances An overall account of investigations on photodynamic phenomena). Leipzig: F.C.W. Vogel 1907.
[2]
Raab O. Uber die wirkung Fluorescirender Stoffe auf Infusorien. Z Biol (Münch) 1900; 39: 524-46.
[3]
Agarwal R, Athar M, Bickers DR, Mukhtar H. Evidence for the involvement of singlet oxygen in the photodestruction by chloroaluminum phthalocyanine tetrasulfonate. Biochem Biophys Res Commun 1990; 173(1): 34-41.
[http://dx.doi.org/10.1016/S0006-291X(05)81017-4] [PMID: 2256924]
[4]
Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992; 55(1): 145-57.
[http://dx.doi.org/10.1111/j.1751-1097.1992.tb04222.x] [PMID: 1603846]
[5]
Hausmann W. The sensitizing effect of hematoporphyrin. Biochem Z 1911; 30: 276-316.
[6]
Policard A. Study on the aspects offered by experimental tumors examined by Woodlight. C R Soc Biol 1924; 91: 1423-4.
[7]
Auler H, Banzer G. Studies on the role of porphyrins in human and animal cancer. Z Krebsforsch 1942; 53(65): 60-8.
[8]
Schwartz S, Absolon K, Vermund H. Some relationships of porphyrins, X-rays and tumors. Med Bull 1955; 27: 7-13.
[9]
Marks R. An overview of skin cancers. Cancer 1995; 75(S2): 607-12.
[http://dx.doi.org/10.1002/1097-0142(19950115)75:2+<607:AID-CNCR2820751402>3.0.CO;2-8] [PMID: 7804986]
[10]
Jeffes EW, McCullough JL, Weinstein GD, Kaplan R, Glazer SD, Taylor JR. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol 2001; 45(1): 96-104.
[http://dx.doi.org/10.1067/mjd.2001.114288] [PMID: 11423841]
[11]
Kurwa HA, Yong-Gee SA, Seed PT, Markey AC, Barlow RJ. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999; 41(3): 414-8.
[http://dx.doi.org/10.1016/S0190-9622(99)70114-3] [PMID: 10459115]
[12]
Smith S, Piacquadio D, Morhenn V, Atkin D, Fitzpatrick R. Short incubation PDT versus 5-FU in treating actinic keratoses. J Drugs Dermatol 2003; 2(6): 629-35.
[PMID: 14711141]
[13]
Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: Phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol 2006; 155(6): 1262-9.
[http://dx.doi.org/10.1111/j.1365-2133.2006.07520.x] [PMID: 17107399]
[14]
Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: Results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003; 48(2): 227-32.
[http://dx.doi.org/10.1067/mjd.2003.49] [PMID: 12582393]
[15]
Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol 2005; 85(5): 424-8.
[http://dx.doi.org/10.1080/00015550510032887] [PMID: 16159735]
[16]
Szeimiesa RM, Karrera S, Radakovic-Fijanb S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 2002; 47(2): 258-62.
[http://dx.doi.org/10.1067/mjd.2002.119649] [PMID: 12140473]
[17]
Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: A prospective, randomized study. J Dermatolog Treat 2003; 14(2): 99-106.
[http://dx.doi.org/10.1080/09546630310012118] [PMID: 12775317]
[18]
Lai HW, Takahashi K, Nakajima M, Tanaka T, Ogura S. Efficiency of aminolevulinic acid (ALA)-photodynamic therapy based on ALA uptake transporters in a cell density-dependent malignancy model. J Photochem Photobiol B 2021; 218: 112191.
[http://dx.doi.org/10.1016/j.jphotobiol.2021.112191] [PMID: 33862352]

© 2024 Bentham Science Publishers | Privacy Policy